Category Archives: Cancer

New Cancer Drugs Top Entries On WHO Essential Medicines List

Source: Health Policy Watch 23rd July, 2019   WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and … Continue reading

Posted in Access to Medicins, Cancer, WHO | Leave a comment

Strong call for transparency on medicine prices, cost of R&D at WHO Fair Pricing Forum

Source: Medicines Law and Policy 24th April, 2019 Picture by James Love.   “Medical innovation has little social value if most people cannot access its benefits…. this is a global human rights issue,” said Mariângela Simão, Assistant Director General at … Continue reading

Posted in Cancer, Drug prices, Price Transparency, Price Transparency, Pricing, R&D, WHO, World Health Assembly | Leave a comment

Rivals have no plans to follow VHI’s decision on cancer drugs

Source: Irish Times 17th April, 2019 Move raises questions of equity between public and private patients VHI will provide wider access to cancer drugs, including Pembrolizumab, for stage three melanoma, and Pertuzumab (Perjeta) for patients with early stage breast cancer. … Continue reading

Posted in Cancer, Drugs | Leave a comment

WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy

Source :Health Policy Watch 15th April, 2019 Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use … Continue reading

Posted in Antibiotics, Cancer, WHO | Leave a comment

Number of people with cancer to double by 2045 if rates continue

Source: Irish Times 11th, April 2019 Report says rise could be contained to 50% if recent trends including screening continue Some trends help to lower rates of cancer, such as reduced smoking rates. “There are some grounds for optimism,” says … Continue reading

Posted in Cancer | Leave a comment

The Cost of Cancer: WHO Report Says Expensive Drugs ‘Impairing’ Access to Cure

Source: NEWS18 1st Feb 2019, New Delhi A recent report by the World Health Organisation (WHO) says the standard treatment for breast cancer can drain 10 years of average annual income in India. Forty-five-year old Virendra Sharma’s father was diagnosed … Continue reading

Posted in Access to Medecines, Cancer, Drug prices, India, Patent | Leave a comment

Time to put a stop to the abuse of orphan drug regulation- the latest scandal

10th Jan 2019, New Delhi Source: Medicines Law and Policy Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch Erasmus medical centre in Rotterdam. For … Continue reading

Posted in Access to Medecines, Cancer, Innovation, orphan drug, Patent, Price hikes, Pricing | Leave a comment